Minutes of the CAT meeting 14-16 May 2025

CHMP PROM minutes for the meeting on 20 January 2025

EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 5: Technical specifications

Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Date of authorisation: 06/02/2009, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Date of authorisation: 06/02/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Voydeya, danicopan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Holoclar, ex vivo expanded autologous human corneal epithelial cells containing stem cells, Date of authorisation: 17/02/2015, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 17, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Stronghold Plus, selamectin,sarolaner, Status: Authorised